Complete remission with bexarotene gel in unilesional folliculotropic mycosis fungoides located on the scalp

Abstract

Bexarotene 1% gel is an effective and generally well-tolerated treatment option for early stage cutaneous T cell lymphoma (CTCL) patients who are resistant or intolerant to other topical therapies, with less than 15% body surface area involvement. 1 Folliculotropic mycosis fungoides (FMF) is the most common subtype of MF and is characterized by hairless, indurated, scaly, erythematous patches, plaques, or tumors that preferentially involve the head, neck, and eyebrow.A 47-year-old male patient with a one-month history of hair loss